213 related articles for article (PubMed ID: 23856543)
1. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
2. Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery.
Xing R; Mustapha O; Ali T; Rehman M; Zaidi SS; Baseer A; Batool S; Mukhtiar M; Shafique S; Malik M; Sohail S; Ali Z; Zahid F; Zeb A; Shah F; Yousaf A; Din F
Biomed Res Int; 2021; 2021():9968602. PubMed ID: 34285920
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
Xu W; Bae EJ; Lee MK
Int J Nanomedicine; 2018; 13():7549-7563. PubMed ID: 30532538
[TBL] [Abstract][Full Text] [Related]
4. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
Nguyen VH; Le KNM; Nguyen MCN
Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
[TBL] [Abstract][Full Text] [Related]
5. Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases.
Chae J; Choi Y; Hong J; Kim N; Kim J; Lee HY; Choi J
ACS Appl Bio Mater; 2024 Apr; 7(4):2175-2185. PubMed ID: 38478917
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies.
Gaur PK; Mishra S; Bajpai M; Mishra A
Biomed Res Int; 2014; 2014():363404. PubMed ID: 24967360
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin.
Ucisik MH; Küpcü S; Schuster B; Sleytr UB
J Nanobiotechnology; 2013 Dec; 11():37. PubMed ID: 24314310
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study.
Shrestha SC; Ghebremeskel K; White K; Minelli C; Tewfik I; Thapa P; Tewfik S
Int J Nanomedicine; 2021; 16():1977-1992. PubMed ID: 33727810
[TBL] [Abstract][Full Text] [Related]
9. Design and Evaluation of SLNs Encapsulated Curcumin-based Topical Formulation for the Management of Cervical Cancer.
Singhai M; Pandey V; Ashique S; Gupta GD; Arora D; Haider T; Mishra N
Anticancer Agents Med Chem; 2023; 23(16):1866-1879. PubMed ID: 37365788
[TBL] [Abstract][Full Text] [Related]
10. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation.
De Gaetano F; Cristiano MC; Venuti V; Crupi V; Majolino D; Paladini G; Acri G; Testagrossa B; Irrera A; Paolino D; Tommasini S; Ventura CA; Stancanelli R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669321
[TBL] [Abstract][Full Text] [Related]
11. Sodium alginate-based smart gastro-retentive drug delivery system of revaprazan loaded SLNs; Formulation and characterization.
Raja HN; Din FU; Shabbir K; Khan S; Alamri AH; Al Awadh AA; Lahiq AA; Alasiri A
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127402. PubMed ID: 37832620
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Effect of Resveratrol-Loaded Solid Lipid Nanoparticles to Relieve Physical Fatigue for Sports Nutrition Supplements.
Qin L; Lu T; Qin Y; He Y; Cui N; Du A; Sun J
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202918
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine-encapsulated solid lipid nanoparticles for skin cancer: physical characterization, stability,
Bhattacharya S; Sharma S
Front Oncol; 2023; 13():1102269. PubMed ID: 37152046
[TBL] [Abstract][Full Text] [Related]
14. Acoustic Cavitation-Assisted Formulation of Solid Lipid Nanoparticles using Different Stabilizers.
Kumar R; Singh A; Garg N
ACS Omega; 2019 Aug; 4(8):13360-13370. PubMed ID: 31460464
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its Effectiveness.
Gupta T; Singh J; Kaur S; Sandhu S; Singh G; Kaur IP
Front Bioeng Biotechnol; 2020; 8():879. PubMed ID: 33178666
[TBL] [Abstract][Full Text] [Related]
16. Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells.
Aljuffali IA; Anwer MK; Ahmed MM; Alalaiwe A; Aldawsari MF; Fatima F; Jamil S
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004415
[TBL] [Abstract][Full Text] [Related]
17. Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits.
El-Say KM; Hosny KM
PLoS One; 2018; 13(8):e0203405. PubMed ID: 30161251
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer:
Li M; Fang G; Zahid F; Saleem R; Ishrat G; Ali Z; Naeem M; Din FU
Heliyon; 2024 May; 10(9):e30290. PubMed ID: 38720725
[TBL] [Abstract][Full Text] [Related]
19. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation.
Al-Amin M; Cao J; Naeem M; Banna H; Kim MS; Jung Y; Chung HY; Moon HR; Yoo JW
Drug Des Devel Ther; 2016; 10():3947-3957. PubMed ID: 27980392
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cytotoxic Activity of 6-Mercaptopurine-Loaded Solid Lipid Nanoparticles in Hepatic Cancer Treatment.
Ergin AD; Oltulu Ç; Koç B
Assay Drug Dev Technol; 2023 Jul; 21(5):212-221. PubMed ID: 37417972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
